Zenosyne Life Sciences Private Limited
About Zenosyne Life Sciences Private Limited
Data last updated:
Zenosyne Life Sciences Private Limited is a private limited company based in Manchal, Telangana, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 07 June 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51909TG2019PTC133196. Its GSTIN is 36AABCZ3790Q1ZH (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ranjith Reddy Pulakanti and Anuradha Pulakanti.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No. 01 – 54 Lingampally Manchal Mandal Ranga Reddy District, Telangana, India – 501508.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.35 Lakh, a decline of 6% compared to the previous year. For the same year it recorded a net loss of ₹15,863 (net margin -1.7%) and EBITDA of ₹10,137 (EBITDA margin 1.1%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 11% over five years.
Company details
Contact details
Zenosyne Life Sciences Private Limited's registered office is in Manchal, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressH.No. 01 – 54 Lingampally Manchal Mandal Ranga Reddy District, Telangana, India – 501508
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Zenosyne Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Zenosyne Life Sciences is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Zenosyne Life Sciences Private Limited, buy the company report.
Financials of Zenosyne Life Sciences Private Limited
FY 2025 filings availableZenosyne Life Sciences Private Limited reported revenue of ₹9.35 Lakh (down 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 6% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 11%. EBITDA fell 47% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10,137 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹15,863 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.1% | ||||
| Net Profit Margin | -1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zenosyne Life Sciences Private Limited, buy the company report.
Board of directors of Zenosyne Life Sciences Private Limited
Zenosyne Life Sciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ranjith Reddy Pulakanti | Director | 07 Jun 2019 | 7 Years 4 Months | Current |
| Anuradha Pulakanti | Director | 12 Feb 2022 | 4 Years 8 Months | Current |
Peer comparison
Zenosyne Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Narayana Health Institutions Private Limited | ₹9.41 Lakh (FY 2022) | Bangalore, Karnataka, India | ||||
| Valor Medicare and Research Private Limited | ₹9.41 Lakh (FY 2019) | 21.0% | Jhabua, Madhya Pradesh, India | |||
| Caremithra Health Systems Private Limited | ₹9.37 Lakh (FY 2023) | 52615.0% | Thiruvananthapuram, Kerala, India | |||
| Hamsa Soham Healthcare Private Limited | ₹9.37 Lakh (FY 2024) | -18.0% | Patna, Bihar, India | |||
| Taruniman Foundation | ₹9.36 Lakh (FY 2019) | Satara, Maharashtra, India | ||||
| Zenosyne Life Sciences Private Limitedthis company | ₹9.35 Lakh (FY 2025) | -₹15,863 | -1.7% | -6.0% | Manchal, Telangana, India | |
| Helix Gene Research Private Limited | ₹9.33 Lakh (FY 2025) | Chandigarh, India | ||||
| Garbhopnishad Foundation | ₹9.3 Lakh (FY 2025) | -34.0% | Jamnagar, Gujarat, India | |||
| Adiques Health Care Private Limited | ₹9.28 Lakh (FY 2024) | 65.0% | Jodhpur, Rajasthan, India | |||
| Medic Aviation Services Private Limited | ₹9.28 Lakh (FY 2025) | 453.0% | Lucknow, Uttar Pradesh, India | |||
| Ambola Health Private Limited | ₹9.27 Lakh (FY 2025) | 1755.0% | Juhi, Uttar Pradesh, India |
To see the full peer comparison of Zenosyne Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Zenosyne Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zenosyne Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Zenosyne Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCZ3790Q1ZH | Telangana | Active | 19 Sep 2019 |
To see the full GST registrations and return filing status of Zenosyne Life Sciences Private Limited, buy the company report.
Recent activity
Zenosyne Life Sciences Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Srikanth Kokkula ceased to be Managing Director on 14 Feb 2022.
Frequently asked questions
Zenosyne Life Sciences is an active private limited company based in Manchal, Telangana, India. The company works in specialty, within the trading industry. It was incorporated on 07 June 2019 (7+ years old) and is registered under CIN U51909TG2019PTC133196.
Zenosyne Life Sciences has 2 current directors:
- Ranjith Reddy Pulakanti - Director
- Anuradha Pulakanti - Director
The latest financial statements of Zenosyne Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Zenosyne Life Sciences is 36AABCZ3790Q1ZH, registered in Telangana.
The CIN (Corporate Identification Number) of Zenosyne Life Sciences is U51909TG2019PTC133196. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zenosyne Life Sciences was incorporated on 07 June 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Zenosyne Life Sciences by revenue are Narayana Health Institutions Private Limited, Valor Medicare and Research Private Limited, Caremithra Health Systems Private Limited, Hamsa Soham Healthcare Private Limited, Taruniman Foundation and 5 more, all in the same principal business activity (other hospital and medical care activities).
Srikanth Kokkula ceased to be Managing Director on 14 Feb 2022. Anuradha Pulakanti was appointed as Director on 12 Feb 2022. Ranjith Reddy Pulakanti was appointed as Director on 07 Jun 2019.
The registered office of Zenosyne Life Sciences is at H.No. 01 – 54 Lingampally Manchal Mandal Ranga Reddy District, Telangana, India – 501508.
Zenosyne Life Sciences operates in the trading industry, in the specialty segment.
Zenosyne Life Sciences can be reached at its registered office: H.No. 01 – 54 Lingampally Manchal Mandal Ranga Reddy District, Telangana, India – 501508.